Anthracyclines and Early Breast Cancer: The End of an Era?

被引：16
作者：
Gianni, Luca [1 ,2 ]
机构：
[1] Ist Tumori Milano, Div Med Oncol, Milan, Italy
[2] Fdn Michelangelo, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 08期
关键词：
ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; FOLLOW-UP; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; EPIRUBICIN; DOCETAXEL; METHOTREXATE; PACLITAXEL;
D O I：
10.1200/JCO.2008.20.1640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1155 / 1157
页数：3
相关论文
共 50 条
  • [21] Anthracyclines and taxanes in the neo/adjuvant treatment of breast cancer: does the sequence matter?
    Bines, J.
    Earl, H.
    Buzaid, A. C.
    Saad, E. D.
    ANNALS OF ONCOLOGY, 2014, 25 (06) : 1079 - 1085
  • [22] Anthracyclines in the management of metastatic breast cancer: state of the art
    Gennari, Alessandra
    D'Amico, Mauro
    EJC SUPPLEMENTS, 2011, 9 (02): : 11 - 15
  • [23] Use of non-anthracycline regimens in early stage breast cancer in Australia
    De Boer, Richard H.
    Chan, Arlene
    Tran, Ben
    Wilcken, Nicholas
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2011, 7 (01) : 4 - 10
  • [24] The Impact of Adding Taxanes to Anthracyclines on Women with Breast Cancer Receiving Adjuvant Chemotherapy
    Hilaj, Erina
    Ymeri, Alketa
    Shpati, Kleva P.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (02)
  • [25] Chemotherapy for early breast cancer: Practices in 2010
    Frenel, J. -S.
    Campone, M.
    JOURNAL DE GYNECOLOGIE OBSTETRIQUE ET BIOLOGIE DE LA REPRODUCTION, 2010, 39 (08): : F79 - F84
  • [26] Targeting anthracyclines in early breast cancer: new candidate predictive biomarkers emerge
    Munro, A. F.
    Cameron, D. A.
    Bartlett, J. M. S.
    ONCOGENE, 2010, 29 (38) : 5231 - 5240
  • [27] Sequential versus concurrent anthracyclines and taxanes as adjuvant chemotherapy of early breast cancer: A meta-analysis of phase III randomized control trials
    Shao, Nan
    Wang, Shenming
    Yao, Chen
    Xu, Xiangdong
    Zhang, Yunjian
    Zhang, Yuanyuan
    Lin, Ying
    BREAST, 2012, 21 (03) : 389 - 393
  • [28] Role of anthracyclines in the era of targeted therapy
    Cortes-Funes, Hernan
    Coronado, Cyntia
    CARDIOVASCULAR TOXICOLOGY, 2007, 7 (02) : 56 - 60
  • [29] Clinical Characteristics and Outcome Trends of Adjuvant Anthracycline and Taxane Regimen for Early Stage Breast Cancer
    Vaid, Ashok K.
    Khurana, Aseem
    Sharma, Devender
    Gautam, Dheeraj
    Wadhwa, Jyoti
    Agarwal, Rajiv
    Kaur, Kanchan
    Arora, Jyoti
    Gupta, Kush
    WORLD JOURNAL OF ONCOLOGY, 2020, 11 (03) : 106 - 111
  • [30] Continued value of adjuvant anthracyclines as treatment for early breast cancer
    Turner, Natalie
    Biganzoli, Laura
    Di Leo, Angelo
    LANCET ONCOLOGY, 2015, 16 (07) : E362 - E369
12345